Global Alpha-1 Lung Disease Market Research Report 2022

Global Alpha-1 Lung Disease Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-1 Lung Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Augmentation Therapy
1.2.3 Cystic Fibrosis(CF)
1.2.4 Non-CF Bronchiectasis(NCFB)
1.2.5 Other
1.3 Market by Application
1.3.1 Global Alpha-1 Lung Disease Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Lung Disease Market Perspective (2017-2028)
2.2 Alpha-1 Lung Disease Growth Trends by Region
2.2.1 Alpha-1 Lung Disease Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alpha-1 Lung Disease Historic Market Size by Region (2017-2022)
2.2.3 Alpha-1 Lung Disease Forecasted Market Size by Region (2023-2028)
2.3 Alpha-1 Lung Disease Market Dynamics
2.3.1 Alpha-1 Lung Disease Industry Trends
2.3.2 Alpha-1 Lung Disease Market Drivers
2.3.3 Alpha-1 Lung Disease Market Challenges
2.3.4 Alpha-1 Lung Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-1 Lung Disease Players by Revenue
3.1.1 Global Top Alpha-1 Lung Disease Players by Revenue (2017-2022)
3.1.2 Global Alpha-1 Lung Disease Revenue Market Share by Players (2017-2022)
3.2 Global Alpha-1 Lung Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-1 Lung Disease Revenue
3.4 Global Alpha-1 Lung Disease Market Concentration Ratio
3.4.1 Global Alpha-1 Lung Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Lung Disease Revenue in 2021
3.5 Alpha-1 Lung Disease Key Players Head office and Area Served
3.6 Key Players Alpha-1 Lung Disease Product Solution and Service
3.7 Date of Enter into Alpha-1 Lung Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Lung Disease Breakdown Data by Type
4.1 Global Alpha-1 Lung Disease Historic Market Size by Type (2017-2022)
4.2 Global Alpha-1 Lung Disease Forecasted Market Size by Type (2023-2028)
5 Alpha-1 Lung Disease Breakdown Data by Application
5.1 Global Alpha-1 Lung Disease Historic Market Size by Application (2017-2022)
5.2 Global Alpha-1 Lung Disease Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alpha-1 Lung Disease Market Size (2017-2028)
6.2 North America Alpha-1 Lung Disease Market Size by Country (2017-2022)
6.3 North America Alpha-1 Lung Disease Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Alpha-1 Lung Disease Market Size (2017-2028)
7.2 Europe Alpha-1 Lung Disease Market Size by Country (2017-2022)
7.3 Europe Alpha-1 Lung Disease Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-1 Lung Disease Market Size (2017-2028)
8.2 Asia-Pacific Alpha-1 Lung Disease Market Size by Country (2017-2022)
8.3 Asia-Pacific Alpha-1 Lung Disease Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Alpha-1 Lung Disease Market Size (2017-2028)
9.2 Latin America Alpha-1 Lung Disease Market Size by Country (2017-2022)
9.3 Latin America Alpha-1 Lung Disease Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-1 Lung Disease Market Size (2017-2028)
10.2 Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2017-2022)
10.3 Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Alpha-1 Lung Disease Introduction
11.1.4 Pfizer Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Baxter
11.2.1 Baxter Company Detail
11.2.2 Baxter Business Overview
11.2.3 Baxter Alpha-1 Lung Disease Introduction
11.2.4 Baxter Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.2.5 Baxter Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Alpha-1 Lung Disease Introduction
11.3.4 AstraZeneca Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.3.5 AstraZeneca Recent Development
11.4 Grifols
11.4.1 Grifols Company Detail
11.4.2 Grifols Business Overview
11.4.3 Grifols Alpha-1 Lung Disease Introduction
11.4.4 Grifols Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.4.5 Grifols Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Detail
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Alpha-1 Lung Disease Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Alpha-1 Lung Disease Introduction
11.6.4 Boehringer Ingelheim Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Detail
11.7.2 Kamada Ltd Business Overview
11.7.3 Kamada Ltd Alpha-1 Lung Disease Introduction
11.7.4 Kamada Ltd Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.7.5 Kamada Ltd Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Alpha-1 Lung Disease Introduction
11.8.4 GlaxoSmithKline Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.8.5 GlaxoSmithKline Recent Development
11.9 CSL Behring
11.9.1 CSL Behring Company Detail
11.9.2 CSL Behring Business Overview
11.9.3 CSL Behring Alpha-1 Lung Disease Introduction
11.9.4 CSL Behring Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.9.5 CSL Behring Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Alpha-1 Lung Disease Introduction
11.10.4 Takeda Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.10.5 Takeda Recent Development
11.11 LFB Biomedicaments
11.11.1 LFB Biomedicaments Company Detail
11.11.2 LFB Biomedicaments Business Overview
11.11.3 LFB Biomedicaments Alpha-1 Lung Disease Introduction
11.11.4 LFB Biomedicaments Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.11.5 LFB Biomedicaments Recent Development
11.12 Abeona Therapeutics
11.12.1 Abeona Therapeutics Company Detail
11.12.2 Abeona Therapeutics Business Overview
11.12.3 Abeona Therapeutics Alpha-1 Lung Disease Introduction
11.12.4 Abeona Therapeutics Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.12.5 Abeona Therapeutics Recent Development
11.13 Biogen
11.13.1 Biogen Company Detail
11.13.2 Biogen Business Overview
11.13.3 Biogen Alpha-1 Lung Disease Introduction
11.13.4 Biogen Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.13.5 Biogen Recent Development
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Detail
11.14.2 Vertex Pharmaceuticals Business Overview
11.14.3 Vertex Pharmaceuticals Alpha-1 Lung Disease Introduction
11.14.4 Vertex Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.14.5 Vertex Pharmaceuticals Recent Development
11.15 Baxalta
11.15.1 Baxalta Company Detail
11.15.2 Baxalta Business Overview
11.15.3 Baxalta Alpha-1 Lung Disease Introduction
11.15.4 Baxalta Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.15.5 Baxalta Recent Development
11.16 Arrowhead Research Corporation
11.16.1 Arrowhead Research Corporation Company Detail
11.16.2 Arrowhead Research Corporation Business Overview
11.16.3 Arrowhead Research Corporation Alpha-1 Lung Disease Introduction
11.16.4 Arrowhead Research Corporation Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.16.5 Arrowhead Research Corporation Recent Development
11.17 ProBioGen
11.17.1 ProBioGen Company Detail
11.17.2 ProBioGen Business Overview
11.17.3 ProBioGen Alpha-1 Lung Disease Introduction
11.17.4 ProBioGen Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.17.5 ProBioGen Recent Development
11.18 Chiesi Pharmaceuticals
11.18.1 Chiesi Pharmaceuticals Company Detail
11.18.2 Chiesi Pharmaceuticals Business Overview
11.18.3 Chiesi Pharmaceuticals Alpha-1 Lung Disease Introduction
11.18.4 Chiesi Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.18.5 Chiesi Pharmaceuticals Recent Development
11.19 Kedrion Group
11.19.1 Kedrion Group Company Detail
11.19.2 Kedrion Group Business Overview
11.19.3 Kedrion Group Alpha-1 Lung Disease Introduction
11.19.4 Kedrion Group Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.19.5 Kedrion Group Recent Development
11.20 ProMetic Life Sciences
11.20.1 ProMetic Life Sciences Company Detail
11.20.2 ProMetic Life Sciences Business Overview
11.20.3 ProMetic Life Sciences Alpha-1 Lung Disease Introduction
11.20.4 ProMetic Life Sciences Revenue in Alpha-1 Lung Disease Business (2017-2022)
11.20.5 ProMetic Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Alpha-1 Lung Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Augmentation Therapy
Table 3. Key Players of Cystic Fibrosis(CF)
Table 4. Key Players of Non-CF Bronchiectasis(NCFB)
Table 5. Key Players of Other
Table 6. Global Alpha-1 Lung Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Alpha-1 Lung Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Alpha-1 Lung Disease Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Alpha-1 Lung Disease Market Share by Region (2017-2022)
Table 10. Global Alpha-1 Lung Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Alpha-1 Lung Disease Market Share by Region (2023-2028)
Table 12. Alpha-1 Lung Disease Market Trends
Table 13. Alpha-1 Lung Disease Market Drivers
Table 14. Alpha-1 Lung Disease Market Challenges
Table 15. Alpha-1 Lung Disease Market Restraints
Table 16. Global Alpha-1 Lung Disease Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Alpha-1 Lung Disease Market Share by Players (2017-2022)
Table 18. Global Top Alpha-1 Lung Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Lung Disease as of 2021)
Table 19. Ranking of Global Top Alpha-1 Lung Disease Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Alpha-1 Lung Disease Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alpha-1 Lung Disease Product Solution and Service
Table 23. Date of Enter into Alpha-1 Lung Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Lung Disease Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Alpha-1 Lung Disease Revenue Market Share by Type (2017-2022)
Table 27. Global Alpha-1 Lung Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Alpha-1 Lung Disease Revenue Market Share by Type (2023-2028)
Table 29. Global Alpha-1 Lung Disease Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Alpha-1 Lung Disease Revenue Market Share by Application (2017-2022)
Table 31. Global Alpha-1 Lung Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Alpha-1 Lung Disease Revenue Market Share by Application (2023-2028)
Table 33. North America Alpha-1 Lung Disease Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Alpha-1 Lung Disease Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Alpha-1 Lung Disease Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Alpha-1 Lung Disease Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Alpha-1 Lung Disease Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Alpha-1 Lung Disease Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Alpha-1 Lung Disease Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Alpha-1 Lung Disease Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Alpha-1 Lung Disease Market Size by Country (2023-2028) & (US$ Million)
Table 43. Pfizer Company Detail
Table 44. Pfizer Business Overview
Table 45. Pfizer Alpha-1 Lung Disease Product
Table 46. Pfizer Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 47. Pfizer Recent Development
Table 48. Baxter Company Detail
Table 49. Baxter Business Overview
Table 50. Baxter Alpha-1 Lung Disease Product
Table 51. Baxter Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 52. Baxter Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Alpha-1 Lung Disease Product
Table 56. AstraZeneca Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Grifols Company Detail
Table 59. Grifols Business Overview
Table 60. Grifols Alpha-1 Lung Disease Product
Table 61. Grifols Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 62. Grifols Recent Development
Table 63. Teva Pharmaceutical Industries Company Detail
Table 64. Teva Pharmaceutical Industries Business Overview
Table 65. Teva Pharmaceutical Industries Alpha-1 Lung Disease Product
Table 66. Teva Pharmaceutical Industries Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 67. Teva Pharmaceutical Industries Recent Development
Table 68. Boehringer Ingelheim Company Detail
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Alpha-1 Lung Disease Product
Table 71. Boehringer Ingelheim Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. Kamada Ltd Company Detail
Table 74. Kamada Ltd Business Overview
Table 75. Kamada Ltd Alpha-1 Lung Disease Product
Table 76. Kamada Ltd Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 77. Kamada Ltd Recent Development
Table 78. GlaxoSmithKline Company Detail
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Alpha-1 Lung Disease Product
Table 81. GlaxoSmithKline Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. CSL Behring Company Detail
Table 84. CSL Behring Business Overview
Table 85. CSL Behring Alpha-1 Lung Disease Product
Table 86. CSL Behring Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 87. CSL Behring Recent Development
Table 88. Takeda Company Detail
Table 89. Takeda Business Overview
Table 90. Takeda Alpha-1 Lung Disease Product
Table 91. Takeda Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 92. Takeda Recent Development
Table 93. LFB Biomedicaments Company Detail
Table 94. LFB Biomedicaments Business Overview
Table 95. LFB Biomedicaments Alpha-1 Lung DiseaseProduct
Table 96. LFB Biomedicaments Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 97. LFB Biomedicaments Recent Development
Table 98. Abeona Therapeutics Company Detail
Table 99. Abeona Therapeutics Business Overview
Table 100. Abeona Therapeutics Alpha-1 Lung DiseaseProduct
Table 101. Abeona Therapeutics Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 102. Abeona Therapeutics Recent Development
Table 103. Biogen Company Detail
Table 104. Biogen Business Overview
Table 105. Biogen Alpha-1 Lung DiseaseProduct
Table 106. Biogen Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 107. Biogen Recent Development
Table 108. Vertex Pharmaceuticals Company Detail
Table 109. Vertex Pharmaceuticals Business Overview
Table 110. Vertex Pharmaceuticals Alpha-1 Lung DiseaseProduct
Table 111. Vertex Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 112. Vertex Pharmaceuticals Recent Development
Table 113. Baxalta Company Detail
Table 114. Baxalta Business Overview
Table 115. Baxalta Alpha-1 Lung DiseaseProduct
Table 116. Baxalta Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 117. Baxalta Recent Development
Table 118. Arrowhead Research Corporation Company Detail
Table 119. Arrowhead Research Corporation Business Overview
Table 120. Arrowhead Research Corporation Alpha-1 Lung DiseaseProduct
Table 121. Arrowhead Research Corporation Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 122. Arrowhead Research Corporation Recent Development
Table 123. ProBioGen Company Detail
Table 124. ProBioGen Business Overview
Table 125. ProBioGen Alpha-1 Lung DiseaseProduct
Table 126. ProBioGen Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 127. ProBioGen Recent Development
Table 128. Chiesi Pharmaceuticals Company Detail
Table 129. Chiesi Pharmaceuticals Business Overview
Table 130. Chiesi Pharmaceuticals Alpha-1 Lung DiseaseProduct
Table 131. Chiesi Pharmaceuticals Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 132. Chiesi Pharmaceuticals Recent Development
Table 133. Kedrion Group Company Detail
Table 134. Kedrion Group Business Overview
Table 135. Kedrion Group Alpha-1 Lung DiseaseProduct
Table 136. Kedrion Group Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 137. Kedrion Group Recent Development
Table 138. ProMetic Life Sciences Company Detail
Table 139. ProMetic Life Sciences Business Overview
Table 140. ProMetic Life Sciences Alpha-1 Lung DiseaseProduct
Table 141. ProMetic Life Sciences Revenue in Alpha-1 Lung Disease Business (2017-2022) & (US$ Million)
Table 142. ProMetic Life Sciences Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha-1 Lung Disease Market Share by Type: 2021 VS 2028
Figure 2. Augmentation Therapy Features
Figure 3. Cystic Fibrosis(CF) Features
Figure 4. Non-CF Bronchiectasis(NCFB) Features
Figure 5. Other Features
Figure 6. Global Alpha-1 Lung Disease Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Alpha-1 Lung Disease Report Years Considered
Figure 12. Global Alpha-1 Lung Disease Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Alpha-1 Lung Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Alpha-1 Lung Disease Market Share by Region: 2021 VS 2028
Figure 15. Global Alpha-1 Lung Disease Market Share by Players in 2021
Figure 16. Global Top Alpha-1 Lung Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Lung Disease as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Alpha-1 Lung Disease Revenue in 2021
Figure 18. North America Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Alpha-1 Lung Disease Market Share by Country (2017-2028)
Figure 20. United States Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Alpha-1 Lung Disease Market Share by Country (2017-2028)
Figure 24. Germany Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Alpha-1 Lung Disease Market Share by Region (2017-2028)
Figure 32. China Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Alpha-1 Lung Disease Market Share by Country (2017-2028)
Figure 40. Mexico Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Alpha-1 Lung Disease Market Share by Country (2017-2028)
Figure 44. Turkey Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Alpha-1 Lung Disease Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 47. Baxter Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 48. AstraZeneca Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 49. Grifols Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 50. Teva Pharmaceutical Industries Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 52. Kamada Ltd Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 54. CSL Behring Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 55. Takeda Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 56. LFB Biomedicaments Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 57. Abeona Therapeutics Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 58. Biogen Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 59. Vertex Pharmaceuticals Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 60. Baxalta Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 61. Arrowhead Research Corporation Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 62. ProBioGen Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 63. Chiesi Pharmaceuticals Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 64. Kedrion Group Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 65. ProMetic Life Sciences Revenue Growth Rate in Alpha-1 Lung Disease Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs